![](/img/cover-not-exists.png)
Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck
Sauter, Alexander, Kloft, Charlotte, Gronau, Silke, Bogeschdorfer, Felix, Erhardt, Thomas, Golze, Wolfram, Schroen, Carsten, Staab, Alexander, Riechelmann, Herbert, Hoermann, KarlLanguage:
english
Journal:
International Journal of Oncology
DOI:
10.3892/ijo.30.4.927
Date:
April, 2007
File:
PDF, 136 KB
english, 2007